Results 161 to 170 of about 212,106 (307)

Supplementary Methods from Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer Using Cell-free DNA Fragmentomics

, 2023
Siwei Wang, Zhijun Xia, Jing You, Xiaolan Gu, Fanchen Meng, Peng Chen, Wanxiangfu Tang, Hua Bao, Jingyuan Zhang, Xue Wu, Yang Shao, Jie Wang, Xianglin Zuo, Lin Xu, Rong Yin   +14 more
openalex   +1 more source

Minimal Residual Disease [PDF]

, 2018
openaire   +2 more sources

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Bone marrow aspirate Cit-H3 was identified as a novel biomarker of minimal residual disease in neuroblastoma. [PDF]

BMC Cancer
Zhang M, Wang X, Liu L, Ni Y, Zhang Y, Hu X, Huang C, Gong B, She T, Chen C.   +9 more
europepmc   +1 more source

Supplementary Data TS1-4 from Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets

, 2023
Urvi A. Shah, Kylee Maclachlan, Andriy Derkach, Meghan Salcedo, Kelly Barnett, Julia Caple, Jenna Blaslov, Linh Tran, Amanda Ciardiello, Miranda Burge, Tala Shekarkhand, Peter Adintori, Justin R. Cross, Matthew J. Pianko, Kinga Hosszu, Devin McAvoy, Sham Mailankody, Neha Korde, Malin Hultcrantz, Hani Hassoun, Carlyn Tan, Sydney X. Lu, Dhwani Patel, Benjamin Diamond, Gunjan L. Shah, Michael Scordo, Oscar Lahoud, David J. Chung, Heather Landau, Saad Z. Usmani, Sergio Giralt, Ying Taur, Ola Landgren, Gladys Block, Torin Block, Jonathan U. Peled, Marcel R.M. van den Brink, Alexander M. Lesokhin   +37 more
openalex   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Feasibility of tumor-informed circulating tumor DNA for detecting minimal residual disease in surgically resected biliary tract cancer. [PDF]

PLoS One
Park Y, Kim KS, Jo H, Kim HP, Kyung DS, Yoo Y, Min SK, Nam EM, Kim K.   +8 more
europepmc   +1 more source

Detection of minimal residual disease in acute lymphoblastic leukemia

, 2005
Matteo Giovanni Della Porta, Luca Malcovati   +1 more
openalex   +1 more source

Statistical Considerations in the Analysis of Minimal Residual Disease

, 2003
Dennis A. Johnston, Theodore F. Zipf
openalex   +1 more source

Regulatory perspective on minimal residual disease flow cytometry testing in multiple myeloma [PDF]

, 2015
Nicole Gormley, Danielle M. Turley, Jennifer S. Dickey, Ann T. Farrell, Gregory H. Reaman, Elizabeth A. Stafford, Lea Carrington, Gerald E. Marti   +7 more
openalex   +1 more source